An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021

We investigated a COVID-19 outbreak of the SARS-CoV-2 Delta variant of concern in a London care home, where 8/21 residents and 14/21 staff had received a single dose of Vaxzevria (ChAdOx1-S; AstraZeneca) vaccine. We identified 24 SARS-CoV-2 infections (16 residents, 8 staff) among 40 individuals (19...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Euro Surveill
Päätekijät: Williams, Sarah V, Vusirikala, Amoolya, Ladhani, Shamez N, Fernandez Ruiz De Olano, Elena, Iyanger, Nalini, Aiano, Felicity, Stoker, Kelly, Gopal Rao, Guduru, John, Laurence, Patel, Bharat, Andrews, Nick, Dabrera, Gavin, Ramsay, Mary, Brown, Kevin E, Lopez Bernal, Jamie, Saliba, Vanessa
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: European Centre for Disease Prevention and Control (ECDC) 2021
Aiheet:
Rapid Communication
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8268653/
https://ncbi.nlm.nih.gov/pubmed/34240699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2807/1560-7917.ES.2021.26.27.2100626
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia